Guerbet

Guerbet : Q1 2024 revenue.

25 Apr 2024 11:45:00 By Nasdaq GlobeNewswire

Guerbet: Financial agenda for 2024

15 Jan 2024 12:00:00 By Nasdaq GlobeNewswire

GUERBET : Revenue at 30 September 2023.

19 Oct 2023 11:45:00 By Nasdaq GlobeNewswire

Guerbet: CHMP positive opinion

12 Oct 2023 11:57:24 By Nasdaq GlobeNewswire

Guerbet: 2023 half-year results

20 Sep 2023 11:45:00 By Nasdaq GlobeNewswire

Guerbet: First-half 2023 revenue

20 Jul 2023 11:46:36 By Nasdaq GlobeNewswire

Guerbet: Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer

17 Jul 2023 13:00:19 By Nasdaq GlobeNewswire

Guerbet: Guerbet strengthens its Executive Committee with two new appointments to accelerate its commercial and industrial development

10 Jul 2023 11:48:16 By Nasdaq GlobeNewswire

Guerbet: Changes in Guerbet's Board of Directors

26 May 2023 11:29:04 By Nasdaq GlobeNewswire

Guerbet: Q1 2023 Revenue

20 Apr 2023 11:49:25 By Nasdaq GlobeNewswire

Guerbet: 2022 annual results

22 Mar 2023 12:45:58 By Nasdaq GlobeNewswire

Guerbet: 2022 revenue

09 Feb 2023 11:46:34 By Nasdaq GlobeNewswire

Guerbet: 2023 Strategic Priorities

16 Jan 2023 12:40:42 By Nasdaq GlobeNewswire

Guerbet: Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under the same price conditions

11 Jan 2023 13:46:47 By Nasdaq GlobeNewswire

Guerbet: Guerbet announces a change in governance for its Artificial Intelligence projects

03 Nov 2022 13:04:18 By Nasdaq GlobeNewswire

Guerbet: Revenue at September 30, 2022

20 Oct 2022 11:45:00 By Nasdaq GlobeNewswire

Guerbet obtains one million euros of public funding from Bpifrance (France 2030 investment plan) for a project developing artificial intelligence for the early detection of pancreatic cancer

26 Sep 2022 12:00:00 By Nasdaq GlobeNewswire

Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)

21 Sep 2022 13:00:00 By Nasdaq GlobeNewswire

Guerbet: 2022 half-year results

21 Sep 2022 11:45:00 By Nasdaq GlobeNewswire

Guerbet: Revenue at June 30, 2022

21 Jul 2022 11:45:00 By Nasdaq GlobeNewswire